CA1282704C - Ocular antihypertensive composition for topical use - Google Patents

Ocular antihypertensive composition for topical use

Info

Publication number
CA1282704C
CA1282704C CA000528282A CA528282A CA1282704C CA 1282704 C CA1282704 C CA 1282704C CA 000528282 A CA000528282 A CA 000528282A CA 528282 A CA528282 A CA 528282A CA 1282704 C CA1282704 C CA 1282704C
Authority
CA
Canada
Prior art keywords
compound
salt
eye
antihypertensive composition
ocular antihypertensive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000528282A
Other languages
English (en)
French (fr)
Inventor
Yujiro Yamamoto
Takahiro Ogawa
Yoshikazu Kuribayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1282704C publication Critical patent/CA1282704C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000528282A 1986-01-31 1987-01-27 Ocular antihypertensive composition for topical use Expired - Fee Related CA1282704C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61020361A JPH0696521B2 (ja) 1986-01-31 1986-01-31 眼局所投与用眼圧降下剤
JP20361/1986 1986-01-31

Publications (1)

Publication Number Publication Date
CA1282704C true CA1282704C (en) 1991-04-09

Family

ID=12024951

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000528282A Expired - Fee Related CA1282704C (en) 1986-01-31 1987-01-27 Ocular antihypertensive composition for topical use

Country Status (9)

Country Link
US (1) US4826879A (US07498051-20090303-C00003.png)
EP (1) EP0235544B1 (US07498051-20090303-C00003.png)
JP (1) JPH0696521B2 (US07498051-20090303-C00003.png)
AU (1) AU591228B2 (US07498051-20090303-C00003.png)
CA (1) CA1282704C (US07498051-20090303-C00003.png)
DE (1) DE3777858D1 (US07498051-20090303-C00003.png)
ES (1) ES2032390T3 (US07498051-20090303-C00003.png)
GR (1) GR3004513T3 (US07498051-20090303-C00003.png)
HU (1) HU199285B (US07498051-20090303-C00003.png)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306731A (en) * 1985-06-14 1994-04-26 Massachusetts Eye And Ear Infirmary Method and products for treating the eye
US5863948A (en) * 1985-06-14 1999-01-26 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5314916A (en) * 1993-04-19 1994-05-24 Alcon Laboratories, Inc. B2 adrenegic agonists and use thereof in the treatment of glaucoma
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
AU2720602A (en) * 2000-11-08 2002-05-21 Bio Concept Lab Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative
CN106075449A (zh) * 2005-07-14 2016-11-09 尼奥塞蒂克斯公司 用于局部脂肪组织治疗的持续释放的增强性脂肪分解性制剂
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
KR101638301B1 (ko) * 2010-01-15 2016-07-08 네오쎄틱스 인코포레이티드 동결건조 케이크 제제
CN105832681A (zh) 2010-11-24 2016-08-10 纽赛蒂克斯公司 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法
CN103664816B (zh) * 2011-01-06 2016-03-02 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826332B2 (ja) * 1974-04-25 1983-06-02 武田薬品工業株式会社 テトラロ−ルカゴウブツ ノ セイゾウホウ
JPS5833219B2 (ja) * 1974-06-12 1983-07-18 武田薬品工業株式会社 テトラロ−ルカゴウブツノ セイゾウホウ
DK254975A (da) * 1974-06-12 1975-12-13 Takeda Chemical Industries Ltd Fremgangsmade til fremstilling af aminotetralolforbindelser
JPS5283826A (en) * 1976-01-01 1977-07-13 Takeda Chem Ind Ltd Tetralol compound
US4402976A (en) * 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
JPS5970653A (ja) * 1982-10-15 1984-04-21 Takeda Chem Ind Ltd 眼圧低下剤
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma

Also Published As

Publication number Publication date
EP0235544A3 (en) 1989-11-29
JPH0696521B2 (ja) 1994-11-30
AU591228B2 (en) 1989-11-30
US4826879A (en) 1989-05-02
EP0235544A2 (en) 1987-09-09
EP0235544B1 (en) 1992-04-01
JPS62178514A (ja) 1987-08-05
HU199285B (en) 1990-02-28
HUT46210A (en) 1988-10-28
ES2032390T3 (es) 1996-07-16
AU6813987A (en) 1987-08-06
DE3777858D1 (de) 1992-05-07
GR3004513T3 (US07498051-20090303-C00003.png) 1993-04-28

Similar Documents

Publication Publication Date Title
CA1282704C (en) Ocular antihypertensive composition for topical use
AU609932B2 (en) Locally administrable 2-amino-3-benzoyl phenylacetic acid derivatives as therapeutic compositions for inflammatory disease
RU2102069C1 (ru) Фармацевтическая композиция для лечения глаукомы
US5438060A (en) Method of reducing elevated intraocular pressure
US4309432A (en) Compositions for treating glaucoma containing a carbostyril
US4382953A (en) Ophthalmic solution for intraocular pressure reduction
EP0114333A2 (en) Pharmaceutical composition
EP0509752B1 (en) Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
EP0695545A1 (en) Use of diphenylethane derivatives for the treatment of glaucoma
US5308849A (en) Method of reducing elevated intraocular pressure
US4764530A (en) Pharmaceutical compositions and their use as mydriatics
EP0277814B1 (en) Anti-glaucoma use of trifluoromethanesulfonamide
EP0728480A1 (en) Use of ifenprodil for treatment of elevated intraocular pressure
EP0375299A1 (en) Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma
EP0759756A1 (en) Pharmaceutical composition for treating glaucoma containing terazosin
KR20190109677A (ko) 세비메린 또는 이의 약학적으로 허용가능한 염을 포함하는 안구건조증의 예방 또는 치료용 점안제
US5428030A (en) Method of reducing elevated intraocular pressure
US4826812A (en) Antiglaucoma agent
US5457126A (en) Use of lodoxamide to treat ophthalmic allergic conditions
EP0396169A2 (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
JPH0778022B2 (ja) 緑内障治療剤
JPS5951928B2 (ja) 緑内障治療剤

Legal Events

Date Code Title Description
MKLA Lapsed